Published in Am J Transl Res on December 01, 2013
Prognostic value of miR-221-3p, miR-342-3p and miR-491-5p expression in colon cancer. Am J Transl Res (2014) 1.07
MicroRNA-139-3p indicates a poor prognosis of colon cancer. Int J Clin Exp Pathol (2014) 0.90
The p53/microRNA connection in gastrointestinal cancer. Clin Exp Gastroenterol (2014) 0.90
Association between miR-125a rs12976445 and survival in breast cancer patients. Am J Transl Res (2014) 0.84
Prognostic Value and Clinicopathology Significance of MicroRNA-200c Expression in Cancer: A Meta-Analysis. PLoS One (2015) 0.79
Prognostic Role of MicroRNA-200c-141 Cluster in Various Human Solid Malignant Neoplasms. Dis Markers (2015) 0.76
Prognostic Role of the MicroRNA-200 Family in Various Carcinomas: A Systematic Review and Meta-Analysis. Biomed Res Int (2017) 0.75
Prognostic significance of microRNA-200c in various types of cancer: An updated meta-analysis of 34 studies. Mol Clin Oncol (2016) 0.75
The expression of microRNA 574-3p as a predictor of postoperative outcome in patients with esophageal squamous cell carcinoma. World J Surg Oncol (2016) 0.75
Prognostic role of miR-200c in various malignancies: a systematic review and meta-analysis. Int J Clin Exp Med (2015) 0.75
Plasma microRNA-9 as a diagnostic and prognostic biomarker in patients with esophageal squamous cell carcinoma. J Int Med Res (2017) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Epithelial-mesenchymal transitions in development and disease. Cell (2009) 39.17
Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A (2008) 33.65
Reporting results of cancer treatment. Cancer (1981) 28.83
The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol (2008) 24.27
Esophageal cancer. N Engl J Med (2003) 15.23
Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol (2008) 10.28
The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem (2008) 10.08
PI3K/Akt signalling pathway and cancer. Cancer Treat Rev (2004) 5.46
Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res (2009) 4.24
MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene (2008) 4.11
MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents. Mol Cancer Ther (2009) 2.50
Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway. Cancer Chemother Pharmacol (2013) 2.09
Genetic polymorphisms and esophageal cancer risk. Int J Cancer (2007) 2.02
Stable expression of miR-200c alone is sufficient to regulate TCF8 (ZEB1) and restore E-cadherin expression. Cell Cycle (2009) 1.97
Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers. J Oncol (2009) 1.84
Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway. Clin Cancer Res (2011) 1.59
Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg (2009) 1.48
Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer. Ann Surg (2014) 1.46
The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma. Clin Sci (Lond) (2011) 1.34
Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer. J Transl Med (2012) 1.31
MiR-200c and HuR in ovarian cancer. BMC Cancer (2013) 1.18
18F-FDG PET/CT has a high impact on patient management and provides powerful prognostic stratification in the primary staging of esophageal cancer: a prospective study with mature survival data. J Nucl Med (2012) 1.18
MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transition. J Ovarian Res (2013) 1.14
A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma. Int J Cancer (2013) 1.10
Circulating miR-200c levels significantly predict response to chemotherapy and prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer. Ann Surg Oncol (2013) 1.10
Serum miR-19a expression correlates with worse prognosis of patients with non-small cell lung cancer. J Surg Oncol (2013) 1.08
Clinical impact of circulating miR-18a in plasma of patients with oesophageal squamous cell carcinoma. Br J Cancer (2013) 1.05
Circulating miR-155 expression in plasma: a potential biomarker for early diagnosis of esophageal cancer in humans. J Toxicol Environ Health A (2012) 1.03
MiR-200c increases the radiosensitivity of non-small-cell lung cancer cell line A549 by targeting VEGF-VEGFR2 pathway. PLoS One (2013) 1.00
Prognostic significance of serum miR-17-5p in lung cancer. Med Oncol (2012) 0.99
miR-200 family expression is downregulated upon neoplastic progression of Barrett's esophagus. World J Gastroenterol (2011) 0.88
Decreased circulating miR-375: a potential biomarker for patients with non-small-cell lung cancer. Gene (2014) 0.86
MicroRNA-139-3p indicates a poor prognosis of colon cancer. Int J Clin Exp Pathol (2014) 0.90
Association of nuclear annexin A1 with prognosis of patients with esophageal squamous cell carcinoma. Int J Clin Exp Pathol (2014) 0.86
The impact of pri-miR-218 rs11134527 on the risk and prognosis of patients with esophageal squamous cell carcinoma. Int J Clin Exp Pathol (2014) 0.85
Association between miR-125a rs12976445 and survival in breast cancer patients. Am J Transl Res (2014) 0.84
Association of the expression of unc-51-Like kinase 1 with lymph node metastasis and survival in patients with esophageal squamous cell carcinoma. Int J Clin Exp Med (2014) 0.76
Angiopoietin-like protein 3 is an indicator of prognosis in esophageal cancer patients. Int J Clin Exp Med (2015) 0.75